Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19.
Nurpeisova A, Khairullin B, Abitaev R, Shorayeva K, Jekebekov K, Kalimolda E, Kerimbayev A, Akylbayeva K, Abay Z, Myrzakhmetova B, Nakhanov A, Absatova Z, Nurabayev S, Orynbayev M, Assanzhanova N, Abeuov K, Kutumbetov L, Kassenov M, Abduraimov Y, Zakarya K. Nurpeisova A, et al. Among authors: kalimolda e. Hum Vaccin Immunother. 2022 Nov 30;18(5):2087412. doi: 10.1080/21645515.2022.2087412. Epub 2022 Aug 12. Hum Vaccin Immunother. 2022. PMID: 35960911 Free PMC article.
[Selection of conditions for effective inactivation of Pseudopestis avium virus (Paramyxoviridae: Orthoavulovirus: Avian orthoavulovirus 1) for the production of a Newcastle disease vaccine].
Jekebekov KK, Assanzhanova NN, Nurpeisova AS, Ryskeldinova SZ, Absatova ZS, Abay ZS, Shayakhmetov YA, Omurtay AD, Moldagulova SU, Kalimolda EZ, Sadikalieva SO, Shorayeva KA, Zakarya KD. Jekebekov KK, et al. Among authors: kalimolda ez. Vopr Virusol. 2023 May 18;68(2):124-131. doi: 10.36233/0507-4088-163. Vopr Virusol. 2023. PMID: 37264847 Russian.
Safety Assessment: a Comparative Analysis of Quantitative Content of Bacterial Endotoxins and Evaluation of Pyrogenicity of the Kazakhstan Vaccine QazCovid-in® against COVID-19.
Jekebekov KK, Nurpeisova AS, Abay ZS, Shorayeva KA, Absatova ZS, Abitayev RT, Kalimolda EZ, Moldagulova SU, Assanzhanova NN, Omurtay AD, Shayakhmetov YA, Sadikaliyeva SO, Barakbayev KB, Kassenov MM, Zakarya KD, Abduraimov YO. Jekebekov KK, et al. Among authors: kalimolda ez. Bull Exp Biol Med. 2024 Feb;176(4):452-456. doi: 10.1007/s10517-024-06045-8. Epub 2024 Mar 15. Bull Exp Biol Med. 2024. PMID: 38491256
Pre-Clinical Safety and Immunogenicity Study of a Coronavirus Protein-Based Subunit Vaccine for COVID-19.
Shorayeva K, Nakhanov A, Nurpeisova A, Chervyakova O, Jekebekov K, Abay Z, Assanzhanova N, Sadikaliyeva S, Kalimolda E, Terebay A, Moldagulova S, Absatova Z, Tulendibayev A, Kopeyev S, Nakhanova G, Issabek A, Nurabayev S, Kerimbayev A, Kutumbetov L, Abduraimov Y, Kassenov M, Orynbayev M, Zakarya K. Shorayeva K, et al. Among authors: kalimolda e. Vaccines (Basel). 2023 Nov 28;11(12):1771. doi: 10.3390/vaccines11121771. Vaccines (Basel). 2023. PMID: 38140175 Free PMC article.
Phylogenetic analysis of prospective M. bovis antigens with the aim of developing candidate vaccines for bovine tuberculosis.
Abay Z, Sadikalieva S, Shorayeva K, Yespembetov B, Sarmykova M, Jekebekov K, Tokkarina G, Absatova Z, Kalimolda E, Shayakhmetov Y, Moldagulova S, Issabek A, Kopeyev S, Omurtay A, Barakbayev K, Kassenov M, Syrym N, Abduraimov Y, Zakarya K, Nurpeisova A. Abay Z, et al. Among authors: kalimolda e. J Genet Eng Biotechnol. 2023 Oct 12;21(1):99. doi: 10.1186/s43141-023-00552-3. J Genet Eng Biotechnol. 2023. PMID: 37823960 Free PMC article.
Safety and Protective Efficacy of a Candidate Vector-Based Vaccine for Bovine Tuberculosis.
Abay Z, Nurpeisova A, Shorayeva K, Sadikaliyeva S, Yespembetov B, Syrym N, Sarmykova M, Jekebekov K, Abitayev R, Tokkarina G, Kalimolda E, Absatova Z, Moldagulova S, Yoo HS, Kassenov M, Zakarya K, Abduraimov Y. Abay Z, et al. Among authors: kalimolda e. Vaccines (Basel). 2023 Jul 4;11(7):1199. doi: 10.3390/vaccines11071199. Vaccines (Basel). 2023. PMID: 37515015 Free PMC article.